Taho Pharmaceuticals Ltd. (TPEX:6467)
235.00
+7.00 (3.07%)
At close: Sep 24, 2026
| Market Cap | 12.32B +23.2% |
| Revenue (ttm) | 1.98M -74.5% |
| Net Income | -238.34M |
| EPS | -4.58 |
| Shares Out | 52.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 969,507 |
| Open | 227.50 |
| Previous Close | 228.00 |
| Day's Range | 217.50 - 235.00 |
| 52-Week Range | 100.50 - 302.00 |
| Beta | -0.81 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |